Androgen Receptor Levels and Association with PIK3CA Mutations and Prognosis in Breast Cancer
暂无分享,去创建一个
W. Gerald | G. Mills | G. Hortobagyi | C. Hudis | M. Carey | B. Hennessy | A. González-Angulo | R. Agarwal | T. Traina | S. Palla | K. Stemke‐Hale | Funda Meric-Berstam
[1] W. Sellers,et al. Drug discovery approaches targeting the PI3K/Akt pathway in cancer , 2008, Oncogene.
[2] Zhi Hu,et al. An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer. , 2008, Cancer research.
[3] Yiling Lu,et al. Pharmacodynamic Markers of Perifosine Efficacy , 2007, Clinical Cancer Research.
[4] Xuming He,et al. Non-parametric quantification of protein lysate arrays , 2007, Bioinform..
[5] K. Calhoun,et al. A New Hormonal Therapy for Estrogen Receptor–Negative Breast Cancer , 2007, World Journal of Surgery.
[6] S. Gabriel,et al. High-throughput oncogene mutation profiling in human cancer , 2007, Nature Genetics.
[7] Gordon B. Mills,et al. The energy sensing LKB1–AMPK pathway regulates p27kip1 phosphorylation mediating the decision to enter autophagy or apoptosis , 2007, Nature Cell Biology.
[8] G. Mills,et al. Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells , 2006, Molecular Cancer Therapeutics.
[9] W. Gerald,et al. An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen , 2006, Oncogene.
[10] A. Miller,et al. Cigarette smoking and breast cancer risk: update of a prospective cohort study , 2006, Breast Cancer Research and Treatment.
[11] R. Pommier,et al. Transgenic introduction of androgen receptor into estrogen-receptor-, progesterone-receptor-, and androgen-receptor-negative breast cancer cells renders them responsive to hormonal manipulation. , 2006, American journal of surgery.
[12] M. Schemper,et al. Androgen receptors, serum androgen levels and survival of breast cancer patients , 2006, Archives of Gynecology and Obstetrics.
[13] Yiling Lu,et al. Exploiting the PI3K/AKT Pathway for Cancer Drug Discovery , 2005, Nature Reviews Drug Discovery.
[14] T. Tot,et al. Immunohistochemical study of androgen receptors in breast carcinoma. Evidence of their frequent expression in lobular carcinoma , 2005, Virchows Archiv.
[15] P. Vogt,et al. Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[16] Hiroyuki Konishi,et al. The PIK3CA gene is mutated with high frequency in human breast cancers , 2004, Cancer biology & therapy.
[17] W. Tilley,et al. Role of the Androgen Receptor in Human Breast Cancer , 2004, Journal of Mammary Gland Biology and Neoplasia.
[18] H. Denk,et al. Androgen receptors frequently are expressed in breast carcinomas , 2003, Cancer.
[19] J. Simard,et al. Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone. , 2003, Endocrine reviews.
[20] N. Harada,et al. Breast carcinoma in women over the age of 85: distinct histological pattern and androgen, oestrogen, and progesterone receptor status , 2003, Histopathology.
[21] R. Dickson,et al. Roles of androgens in the development, growth, and carcinogenesis of the mammary gland , 2002, The Journal of Steroid Biochemistry and Molecular Biology.
[22] Charles R Cantor,et al. The use of MassARRAY technology for high throughput genotyping. , 2002, Advances in biochemical engineering/biotechnology.
[23] Christian A. Rees,et al. Molecular portraits of human breast tumours , 2000, Nature.
[24] M. Bryś. Androgens and androgen receptor: do they play a role in breast cancer? , 2000, Medical science monitor : international medical journal of experimental and clinical research.
[25] J. Clements,et al. Prostate-specific antigen and gross cystic disease fluid protein-15 are co-expressed in androgen receptor-positive breast tumours. , 1998, British Journal of Cancer.
[26] D. Horsfall,et al. Expression of the androgen receptor and an androgen-responsive protein, apolipoprotein D, in human breast cancer. , 1996, British Journal of Cancer.
[27] T. H. van der Kwast,et al. The clinical significance of androgen receptors in breast cancer and their relation to histological and cell biological parameters. , 1996, European journal of cancer.
[28] B. Asselain,et al. Prognostic value of steroid receptors after long-term follow-up of 2257 operable breast cancers. , 1996, British Journal of Cancer.
[29] K. Schulz,et al. Androgen receptor mediated growth control of breast cancer and endometrial cancer modulated by antiandrogen- and androgen-like steroids , 1996, The Journal of Steroid Biochemistry and Molecular Biology.
[30] D. Horsfall,et al. Androgens induce divergent proliferative responses in human breast cancer cell lines , 1995, The Journal of Steroid Biochemistry and Molecular Biology.
[31] K. Schulz,et al. Estrogen and androgen receptor mediated stimulation and inhibition of proliferation by androst-5-ene-3β,17β-diol in human mammary cancer cells , 1993, The Journal of Steroid Biochemistry and Molecular Biology.
[32] J. Isola. Immunohistochemical demonstration of androgen receptor in breast cancer and its relationship to other prognostic factors , 1993, The Journal of pathology.
[33] J. Søreide,et al. Progesterone-binding cyst protein (PBCP = GCDFP-24) and steroid hormone receptors as markers of differentiation in breast cancer. Inverse relation of distribution in normal and malignant tissue of the same breast. , 1991, Anticancer research.
[34] W D Dupont,et al. Prognostic significance of estrogen receptor status in breast cancer in relation to tumor stage, axillary node metastasis, and histopathologic grading , 1984, Cancer.